Literature DB >> 22878404

Evaluation of left ventricular diastolic function after valve replacement in aortic stenosis using exercise Doppler echocardiography.

Jeong-Sook Seo1, Min-Kyoung Jang, Eun-Young Lee, Sung-Cheol Yun, Dae-Hee Kim, Jong-Min Song, Duk-Hyun Kang, Jae-Kwan Song.   

Abstract

BACKGROUND: The aim of the present study was to evaluate the mechanism of diastolic dysfunction (DD) after aortic valve replacement (AVR) in patients with aortic stenosis (AS). METHODS AND
RESULTS: Supine bicycle exercise Doppler echocardiography (EDE) with measurement of early diastolic peak velocities of transmitral flow (E) and mitral septal annular movement (E') was performed in 38 patients with AS at least 24 months after AVR and in 19 sex- and age-matched normal controls. AS patients had a 27.4±32.7% decrease in the ratio of left ventricular (LV) mass index to LV end-diastolic volume index (LVMI/LVEDVI) after AVR. Pre-AVR E' was significantly lower in AS patients (4.3±1.6 cm/s vs. 7.7±1.6 cm/s, P<0.005), resulting in a higher E/E' (16.7±5.4 vs. 9.3±1.8, P<0.001). E/E' at rest did not change significantly after AVR. Both E and E' increased progressively with exercise, and the increase in E' (P<0.001) but not E (P=0.675) was greater in normal controls than in AS patients (P<0.001). Peak E/E' >13 during EDE was more common in AS patients than in controls (89.5%, 34/39 vs. 0%, 0/19, P<0.001). On multivariate analysis, LVMI/LVEDVI (Y=8.703+4.199X, r=0.433, P=0.001) was the only factor associated with peak E/E' during EDE.
CONCLUSIONS: Persistent DD is present after AVR, due primarily to failure in normal physiologic augmentation of LV relaxation during exercise, associated with incomplete or inadequate regression of LV hypertrophy.

Entities:  

Mesh:

Year:  2012        PMID: 22878404     DOI: 10.1253/circj.cj-12-0446

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  How to relate diastolic left ventricular dysfunction to the results of stress echocardiography in aortic stenosis?

Authors:  Thomas Bartel; Silvana Müller
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

2.  The impact of age on the postoperative response of the diastolic function and left ventricular mass regression after surgical or transcatheter aortic valve replacement for severe aortic stenosis.

Authors:  Teruya Nakamura; Koichi Toda; Toru Kuratani; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Yoshiki Sawa
Journal:  Surg Today       Date:  2016-12-24       Impact factor: 2.549

3.  Impact of Valvuloarterial Impedance on Concentric Remodeling in Aortic Stenosis and Its Regression after Valve Replacement.

Authors:  Jeong Yoon Jang; Jeong-Sook Seo; Byung Joo Sun; Dae-Hee Kim; Jong-Min Song; Duk-Hyun Kang; Jae-Kwan Song
Journal:  J Cardiovasc Ultrasound       Date:  2016-09-26

4.  The Degree of Cardiac Remodelling before Overload Relief Triggers Different Transcriptome and miRome Signatures during Reverse Remodelling (RR)-Molecular Signature Differ with the Extent of RR.

Authors:  Patrícia G Rodrigues; Daniela Miranda-Silva; Xidan Li; Cláudia Sousa-Mendes; Ricardo Martins-Ferreira; Zaher Elbeck; Adelino F Leite-Moreira; Ralph Knöll; Inês Falcão-Pires
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

5.  Early detection of subclinical ventricular deterioration in aortic stenosis with cardiovascular magnetic resonance and echocardiography.

Authors:  Seung-Pyo Lee; Sung-Ji Park; Yong-Jin Kim; Sung-A Chang; Eun-Ah Park; Hyung-Kwan Kim; Whal Lee; Sang-Chol Lee; Seung Woo Park; Dae-Won Sohn; Yeon-Hyeon Choe
Journal:  J Cardiovasc Magn Reson       Date:  2013-08-28       Impact factor: 5.364

6.  Variable Hemodynamic Responses during Diastolic Stress Echocardiography in Patients Who Have Relaxation Abnormality with Possible Elevated Filling Pressure.

Authors:  Jeong Yoon Jang; Sahmin Lee; Dae Hee Kim; Jong Min Song; Duk Hyun Kang; Jae Kwan Song
Journal:  Korean Circ J       Date:  2018-08       Impact factor: 3.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.